Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bait Bakfar Ltd (BKFR) Fair Value & Analysis

Healthcare · Il · Market cap 1.0B ILA

Price14.29 ILA
Fair Value9.89 ILA
Upside-30.8%
Quality95/100
Evidence: High Range 7.00 ILA – 13.74 ILA

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bait Bakfar Ltd (BKFR) currently trades at 14.29 ILA, while our model-based Fair Value estimate is 9.89 ILA — implying the stock looks roughly 30.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Bait Bakfar Ltd manages and operates assisted living networks in Israel. The company offers health, welfare, and leisure services for the elderly population. Bait Bakfar Ltd was founded in 1988 is based in Kfar Saba, Israel.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) +19% Fresenius SE (FSNUY) -24% 5225 (5225) -39% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) +37% Tenet Healthcare Corporation (THC) +86%

Frequently asked questions

Is Bait Bakfar Ltd (BKFR) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 9.89 ILA versus a price of 14.29 ILA — about −31% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BKFR?
Our 21-model fair value for Bait Bakfar Ltd is 9.89 ILA (as of Jun 24, 2026), built from audited fundamentals. The current price is 14.29 ILA.
What is the quality score of BKFR?
Bait Bakfar Ltd has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.